Polyzois Makras - Publications

Response to Letter to the Editor on "Romosozumab for the treatment of thalassemia-associated osteoporosis in two female patients".

Journal: JBMR plus

Published: June 16, 2026

Vitamin D Levels and Skeletal Quality of Life in Adult Langerhans Cell Histiocytosis.

Journal: Endocrine connections

Published: May 27, 2026

Challenges in Sequential Antiresorptive Therapy After Long-Term Denosumab Discontinuation: A Case Report and Narrative Review of the Literature.

Journal: Journal of clinical medicine

Published: May 24, 2026

Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 21, 2026

Alendronate for 6 or 12 months following denosumab discontinuation in women with postmenopausal osteoporosis: A prospective observational study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 10, 2026

Real-world data for effectiveness and safety of palopegteriparatide in patients with chronic hypoparathyroidism: the PaTH REAL study.

Journal: European journal of endocrinology

Published: February 08, 2026

Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.

Journal: Frontiers in endocrinology

Published: January 08, 2026

Artificial intelligence vs human opportunistic detection of vertebral fractures in routine CT scans: results of a pilot study.

Journal: Hormones (Athens, Greece)

Published: December 29, 2025

The use of denosumab in rare bone diseases in adults: a systematic review from the ECTS Rare Bone Disease Action Group.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 13, 2025

The use of denosumab in rare bone diseases in adults: a systematic review from the ECTS Rare Bone Disease Action Group.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 13, 2025

Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosis.

Journal: Bone reports

Published: November 05, 2025

Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS).

Journal: Bone

Published: October 19, 2025